Avraham Caspi

Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment

Sorel Goland, Sara Shimoni, Taiba Zornitzki et al. · Journal of Clinical Gastroenterology · 2006 · 160 citations

Heart Failure, Metabolic Disorder, Pathology +25

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

Uri Goldbourt, Solomon Behar, Henrietta Reicher-Reiss et al. · The American Journal of Cardiology · 1993 · 157 citations

Metabolic Syndrome, Secondary Prevention Trial, Cardiovascular Disease +8

Differential Effects of Coronary Artery Stenosis on Myocardial Function: The Value of Myocardial Strain Analysis for the Detection of Coronary Artery Disease

Sara Shimoni, Gera Gendelman, Oded Ayzenberg et al. · Journal of the American Society of Echocardiography · 2011 · 120 citations

Myocardial Function, Radiology, Cardiovascular Disease +13

Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension – A Multi-Center Randomized Study

Edo Kaluski, Gad Cotter, Marina Leitman et al. · Cardiology · 2007 · 103 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +16

MULTICENTER, DOUBLEBLIND PLACEBO CONTROLLED STUDY OF LONG TERMENDOTHELIN BLOCKADE WITH BOSENTAN IN CHRONIC HEART FAILURE RESULTS OF THE REACH-1 TRIAL. ABSTRACT

Milton Packer, Avraham Caspi, Vincent Charlon · 1998 · 83 citations

Heart Failure, Cardiovascular Disease, Cardiovascular Pharmacology +5